1999). Substantial evidence indicates NF-κB activation to be a key event in the progression of AP (Jakkampudi et al. 2016); therefore, inhibition of NF-κB activation and proinflammatory cytokines release may be a good therapeutic strategy for the attenuation of AP. Here, NFKB1 is linked to alkaline phosphatase measurement.